• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国超重和肥胖的患病率:“肥胖防治联盟”开展的2020年Obepi - 罗氏研究

Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the "Ligue Contre l'Obésité".

作者信息

Fontbonne Annick, Currie Andrew, Tounian Patrick, Picot Marie-Christine, Foulatier Olivier, Nedelcu Marius, Nocca David

机构信息

Centre of Clinical Investigation, Inserm, Montpellier University Hospital, 34295 Montpellier, France.

Centre for Epidemiology and Population Health, Inserm, Paris-Saclay University, USQV, 94805 Villejuif, France.

出版信息

J Clin Med. 2023 Jan 25;12(3):925. doi: 10.3390/jcm12030925.

DOI:10.3390/jcm12030925
PMID:36769573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9918095/
Abstract

Obepi-Roche 2020 by the "Ligue Contre l'Obésité" (League Against Obesity) estimated overweight and obesity prevalence in France. The adopted methodology was chosen to be as similar as possible to that of a series of quota-based surveys conducted every three years from 1997 to 2012 (Obepi-Roche studies). The 2020 survey was conducted online from 24th September to 5th October 2020 by the Odoxa polling institute on a sample of metropolitan French subjects aged 18 years or over. Participants ( = 9598) self-measured their height and weight according to detailed instructions. Prevalence estimates were produced for all categories of body mass index. The prevalence of excess weight was 47.3% (17.0% of subjects with obesity), with higher values in the north and east of France. When comparing these 2020 estimates to previous Obepi-Roche estimates in order to visualize trends since 1997, it appeared that overweight fluctuated around 30%, and obesity prevalence increased steadily at a rapid pace. The increase was even steeper in the youngest age groups and for severe and complex obesity. Given the slightly different methodologies between the 1997-2012 studies and the 2020 survey, the worrying trends in obesity prevalence since 1997 must be confirmed, calling for a reedition of the Obepi-Roche series.

摘要

“反肥胖联盟”开展的2020年奥贝皮-罗氏研究估算了法国超重和肥胖的患病率。所采用的方法尽可能与1997年至2012年每三年进行一次的一系列基于配额的调查(奥贝皮-罗氏研究)的方法相似。2020年的调查由奥多克萨民意调查机构于2020年9月24日至10月5日在线进行,样本为18岁及以上的法国本土受试者。参与者(n = 9598)根据详细说明自行测量身高和体重。对所有体重指数类别进行了患病率估算。超重患病率为47.3%(肥胖受试者占17.0%),法国北部和东部的患病率更高。为了观察自1997年以来的趋势,将2020年的这些估算值与之前奥贝皮-罗氏研究的估算值进行比较时,发现超重率在30%左右波动,肥胖患病率则快速稳步上升。在最年轻的年龄组以及重度和复杂肥胖人群中,增长更为显著。鉴于1997 - 2012年研究与2020年调查的方法略有不同,1997年以来肥胖患病率令人担忧的趋势必须得到证实,这就需要重新开展奥贝皮-罗氏系列研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/10e3c9acd8a1/jcm-12-00925-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/841887162981/jcm-12-00925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/9cbedd91da7d/jcm-12-00925-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/4c439bacdb4f/jcm-12-00925-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/a482fa8ec829/jcm-12-00925-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/10e3c9acd8a1/jcm-12-00925-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/841887162981/jcm-12-00925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/9cbedd91da7d/jcm-12-00925-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/4c439bacdb4f/jcm-12-00925-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/a482fa8ec829/jcm-12-00925-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a7d/9918095/10e3c9acd8a1/jcm-12-00925-g005.jpg

相似文献

1
Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the "Ligue Contre l'Obésité".法国超重和肥胖的患病率:“肥胖防治联盟”开展的2020年Obepi - 罗氏研究
J Clin Med. 2023 Jan 25;12(3):925. doi: 10.3390/jcm12030925.
2
Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006.监测法国的肥胖流行情况:1997 - 2006年肥胖流行病学调查
Obesity (Silver Spring). 2008 Sep;16(9):2182-6. doi: 10.1038/oby.2008.285.
3
Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness.法国7至9岁儿童的体重指数:肥胖、超重和消瘦的发生率
Int J Obes Relat Metab Disord. 2002 Dec;26(12):1610-6. doi: 10.1038/sj.ijo.0802146.
4
[Why and how to use the new body mass index curves for children].[为何以及如何使用儿童新的体重指数曲线]
Arch Pediatr. 2010 Dec;17(12):1709-15. doi: 10.1016/j.arcped.2010.09.018. Epub 2010 Nov 2.
5
Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.2012 年法国 2 型糖尿病:ObEpi 调查结果。
Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 2014 Dec 24.
6
Underweight and overweight among children and adolescents in Tuscany (Italy). Prevalence and short-term trends.意大利托斯卡纳地区儿童和青少年的体重过轻与超重情况。患病率及短期趋势
J Prev Med Hyg. 2008 Mar;49(1):13-21.
7
Overweight according to geographical origin and time spent in France: a cross sectional study in the Paris metropolitan area.根据地理位置和在法国停留时间判断超重:巴黎大都市区的横断面研究。
BMC Public Health. 2012 Oct 31;12:937. doi: 10.1186/1471-2458-12-937.
8
The prevalence and trends of overweight and obesity among Lithuanian adults, 1994-2012.立陶宛成年人超重和肥胖的流行率和趋势,1994-2012 年。
Public Health. 2014 Jan;128(1):91-5. doi: 10.1016/j.puhe.2013.10.010. Epub 2013 Dec 17.
9
Secular trends in overweight and obesity among Finnish adolescents in 1977-1999.1977 - 1999年芬兰青少年超重和肥胖的长期趋势。
Int J Obes Relat Metab Disord. 2002 Apr;26(4):544-52. doi: 10.1038/sj.ijo.0801928.
10
Prevalence of age-specific and sex-specific overweight and obesity in Ontario and Quebec, Canada: a cross-sectional study using direct measures of height and weight.加拿大安大略省和魁北克省特定年龄和性别的超重与肥胖患病率:一项使用身高和体重直接测量法的横断面研究
BMJ Open. 2018 Sep 5;8(9):e022029. doi: 10.1136/bmjopen-2018-022029.

引用本文的文献

1
Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).在一项多中心、开放标签、平行组、随机对照试验中,不同生活方式干预方法在将司美格鲁肽3.0毫克实用处方途径整合到体重管理服务中的有效性(STRIVE研究)的结果。
Metabolites. 2025 Jun 13;15(6):398. doi: 10.3390/metabo15060398.
2
A safe path to bariatric surgery: Mental health disorders in pre-operative patients.减肥手术的安全路径:术前患者的心理健康障碍
Compr Psychoneuroendocrinol. 2025 May 15;23:100300. doi: 10.1016/j.cpnec.2025.100300. eCollection 2025 Aug.
3

本文引用的文献

1
Evolution of the prevalence of obesity in the adult population in France, 2013-2016: the Constances study.法国成年人肥胖患病率的演变:2013-2016 年康斯坦斯研究。
Sci Rep. 2021 Jul 8;11(1):14152. doi: 10.1038/s41598-021-93432-0.
2
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.在英格兰 690 万人中,体重指数与 COVID-19 严重程度的关联:一项前瞻性、基于社区的队列研究。
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359. doi: 10.1016/S2213-8587(21)00089-9. Epub 2021 Apr 28.
3
Prevalence of obesity among adult inpatients with COVID-19 in France.
Cardiovascular, Hemodynamic, and Anthropometric Adaptations Induced by Walking Training at FATmax in Obese Males and Females over 45 Years Old.
45岁以上肥胖男性和女性在脂肪代谢功能上限(FATmax)强度下进行步行训练所引发的心血管、血流动力学及人体测量学适应性变化
Int J Environ Res Public Health. 2025 Apr 29;22(5):701. doi: 10.3390/ijerph22050701.
4
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
5
Organized Breast Cancer Screening in Diabetic Women: A Prospective Study Among 100,000 Women from the Grand-Est Region (France), from 2020 to 2022.糖尿病女性的有组织乳腺癌筛查:2020年至2022年对法国大东部地区10万名女性进行的一项前瞻性研究。
Eur J Breast Health. 2025 Mar 25;21(2):173-181. doi: 10.4274/ejbh.galenos.2025.2025-1-4. Epub 2025 Mar 18.
6
Associations between dietary diversity and self-rated health in a transverse study of four local food systems (French Guiana, Guadeloupe, Portugal and Senegal).在对四个地方食物系统(法属圭亚那、瓜德罗普岛、葡萄牙和塞内加尔)的横向研究中,饮食多样性与自评健康之间的关联。
BMC Public Health. 2025 Feb 28;25(1):823. doi: 10.1186/s12889-025-21872-8.
7
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study.司美格鲁肽(Wegovy)在法国成年人中的使用情况:一项全国性药物利用研究。
BioDrugs. 2025 Mar;39(2):321-332. doi: 10.1007/s40259-024-00699-6. Epub 2025 Feb 11.
8
Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden.泛发性脓疱型银屑病:一项关于患者特征和临床负担的多中心研究。
Orphanet J Rare Dis. 2025 Feb 8;20(1):61. doi: 10.1186/s13023-025-03559-w.
9
Endoscopic sleeve gastroplasty versus lifestyle modifications for class II obesity patients: a French cost-effectiveness analysis.内镜袖状胃成形术与生活方式改变对II类肥胖患者的疗效比较:一项法国成本效益分析。
Surg Endosc. 2025 Feb;39(2):1333-1340. doi: 10.1007/s00464-024-11487-2. Epub 2025 Jan 9.
10
Ten-year postintervention follow-up of adolescents participating in the management of overweight and social inequalities (PRALIMAP-INÈS intervention): the PRALIMAP-CINeCO survey protocol.青少年参与超重和社会不平等管理的干预后 10 年随访(PRALIMAP-INÈS 干预):PRALIMAP-CINeCO 调查方案。
BMJ Open. 2024 Sep 12;14(9):e083090. doi: 10.1136/bmjopen-2023-083090.
法国新冠肺炎成年住院患者中的肥胖患病率。
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564. doi: 10.1016/S2213-8587(20)30160-1. Epub 2020 May 18.
4
Biases in self-reported height and weight measurements and their effects on modeling health outcomes.自我报告的身高和体重测量偏差及其对健康结果建模的影响。
SSM Popul Health. 2019 May 10;7:100405. doi: 10.1016/j.ssmph.2019.100405. eCollection 2019 Apr.
5
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.肥胖、营养不良与气候变化的全球综合征:《柳叶刀》委员会报告
Lancet. 2019 Feb 23;393(10173):791-846. doi: 10.1016/S0140-6736(18)32822-8. Epub 2019 Jan 27.
6
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.25年间195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.
7
The French CONSTANCES population-based cohort: design, inclusion and follow-up.法国基于人群的CONSTANCES队列研究:设计、纳入与随访。
Eur J Epidemiol. 2015 Dec;30(12):1317-28. doi: 10.1007/s10654-015-0096-4. Epub 2015 Oct 31.
8
Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.2012 年法国 2 型糖尿病:ObEpi 调查结果。
Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 2014 Dec 24.
9
Global nutrition transition and the pandemic of obesity in developing countries.全球营养转型与发展中国家肥胖症流行。
Nutr Rev. 2012 Jan;70(1):3-21. doi: 10.1111/j.1753-4887.2011.00456.x.
10
Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006.监测法国的肥胖流行情况:1997 - 2006年肥胖流行病学调查
Obesity (Silver Spring). 2008 Sep;16(9):2182-6. doi: 10.1038/oby.2008.285.